Fresenius Kabi to acquire infusion pump maker Ivenix for $240M upfront

Germany's Fresenius Kabi signed a definitive agreement to acquire US-based medical technology firm Ivenix. The deal includes an upfront payment of $240 million plus milestone payments tied to commercial and operating targets, with closing expected mid-2022.

“German healthcare company Fresenius Kabi has signed a definitive agreement to acquire US-based medical technology firm Ivenix.”medicaldevice-network.com

• 1 source
• medicaldevice-network.comFresenius Kabi to acquire medical technology company IvenixApr 1, 2022

Summarized from public sources; check the original articles before acting on it.